Is There Any Parameter Helpful for Predicting a Suitable Candidate for Mite Immunotherapy?

Iranian Journal of Allergy, Asthma and Immunology

Volumn 15, Issue 2, 2016, Pages 105-111

  Karaman, Sait ^a   Can, Demet ^a   Erdem, Semiha Bahçeci ^a   Nacaroǧlu, Hikmet Tekin ^a   Karkiner, Canan Şule ^a   Günay, Ilker ^a  

^a DR BEHÇET UZ CHILDREN'S HOSPITAL   (Turkey)

Author keywords

Allergen immunotherapy; Asthma; Children; Immunoglobulin E; Mite

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; ALLERGEN;

ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOPHAGOIDES; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; HOUSE DUST ALLERGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MILD PERSISTENT ASTHMA; PRICK TEST; REMISSION; RETROSPECTIVE STUDY; RHINITIS; SENSITIVITY AND SPECIFICITY; SKIN TEST; SUBCUTANEOUS IMMUNOTHERAPY; WHEEZING; ANIMAL; ASTHMA; CLINICAL TRIAL; COMPARATIVE STUDY; DESENSITIZATION; IMMUNOLOGY; PRESCHOOL CHILD; PYROGLYPHIDAE;

ALLERGENS; ANIMALS; ASTHMA; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; PYROGLYPHIDAE; REMISSION INDUCTION;

EID: 84964037930     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol 2013; 131(5):1288-96.
2. Soyka MB, Van De Veen W, Holzmann D, Akdis M, Akdis CA. Scientific foundations of allergen-specific immunotherapy for allergic disease. Chest 2014; 146(5):1347-57.
3. Özdemir Ö. The local and systemic reactions due to sublingual immunotherapy: Is anaphylaxis associated with therapy. Iran J Allergy Asthma Immunol 2015; 14(2):228-30.
4. Ciprandi G, Silvestri M. Serum specific IgE: A biomarker of response to allergen immunotherapy. J Investig Allergol Clin Immunol 2014; 24(1):35-9.
5. Ciprandi G, Toska MA, Silvestri M. The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy. Expert Rev Clin Immunol 2014; 10(3):321-4.
6. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2014 [updated 2014; accesed 2015 Jun 10]. Available from URL: Http://www.ginasthma.org/guidelines-gina-report-global-strategy-for-asthma.html.
7. Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J 2009; 33(4):897-906
8. Brand PL, Baraldi E, Bisgaard H, Boner AL, Castro-Rodriguez JA, Custovic A, et al. Definition, assessment and treatment of wheezing disorders in preschool children: An evidence-based approach. Eur Respir J 2008; 32(4):1096-110
9. Cazzoletti L, Corsico AG, Albicini F, Di Vincenzo EMG, Gini E, Grosso A, et al. The course of asthma in young adults: A population-based nine-year follow-up on asthma remission and control. PLOS ONE 2014; 9(1):e86956.
10. Durham SR, Emminger W, Kapp A, De Monchy JG, Rak S, Scadding GK, et al. SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 2012; 129(3):717-25.
11. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study. J Allergy Clin Immunol 2010; 126(5):969-75.
12. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A, et al. PAT Investigator Group: Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62(8):943-8.
13. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011; 127(1):18-27.
14. Akdis CA. Therapies for allergic inflammation: Refining strategies to induce tolerance. Nat Med 2012; 18(5):736-79.
15. Calderón MA, Casale T, Cox L, Akdis CA, Burks AW, Nelson HS, et al. Allergen immunotherapy: A new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report. Allergy 2013; 68(7):825-8.
16. Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010; (8):CD001186.
17. Yukselen A, Kendirli SG. Role of immunotherapy in the treatment of allergic asthma. World J Clin cases 2014; 2(12):859-65.
18. Zhang X, Li MR, Wang C, Wang XN, Zhang HL, Lin J, et al.Clinical efficacy of a standardized specific immunotherapy against house dust mite in 85 asthmatic children. Zhonghua Er Ke Za Zhi 2010; 48(7):526-30.
19. Tabar AI, Arroabarren E, Echechipía S, García BE, Martin S, Alvarez-Puebla MJ. Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy. J Allergy Clin Immunol 2011; 127(1):57-63.
20. Di Lorenzo G, Mansueto P, Pacor ML, Rizzo M, Castello F, Martinelli N, et al. Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. J Allergy Clin Immunol 2009; 123(5):1103-10.
21. Li Q, Li M, Yue W, Zhou J, Li R, Lin J et al. Predictive factors for clinical response to allergy immunotherapy in children with asthma and rhinitis. Int Arch Allergy Immunol 2014; 164(3):210-7.
22. Tosca M, Silvestri M, Accogli A, Rossi GA, Ciprandi G. Serum-specific IgE and allergen immunotherapy in allergic children. Immunotherapy 2014; 6(1):29-33.